Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Global Bio-chem Technology Group Co. Ltd. (0809) Stock Price & Analysis

0809 Stock Chart & Stats

HK$0.35HK$0.00(0.00%)
At close: 1:45 PM GMT+8
HK$0.35HK$0.375HK$0.4HK$0.42511 Aug24 Aug7 Sep21 Sep5 Oct20 Oct2 Nov
Day’s Range
HKD 0.35 - HKD 0.35
52-Week Range
HKD 0.31 - HKD 0.89
Previous Close
HKD 0.35
Volume
N/A
Average Volume (3M)
236.16K
Market Cap
HKD 565.36M
Enterprise Value
HKD 4.29B
Total Cash (Recent Filing)
HKD 126.34M
Total Debt (Recent Filing)
HKD 1.86B
Price to Earnings (P/E)
1.7
Beta
0.31
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 15, 2012
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Diversified End-Market Exposure

Serving food, beverage, pharmaceutical, and industrial customers gives the company exposure to multiple demand pools. This breadth can reduce reliance on one end market and supports a durable platform for selling corn-derived ingredients across applications over the next several quarters.

Product Portfolio Breadth

The company participates across starch, modified starch, sweeteners, downstream ingredients and co-products. A broader corn-derived portfolio can support different customer needs, improve product-mix flexibility and create more opportunities to capture value beyond basic commodity processing.

Debt Reduction From Prior Years

Debt of roughly HK$1.8B in 2025 was materially lower than in prior years, indicating some deleveraging. If maintained, this reduction could ease refinancing pressure and improve financial flexibility, although negative equity still limits the benefit.

Bears Say

Negative Equity And High Leverage

Persistent negative shareholders’ equity and large debt indicate structural balance-sheet weakness rather than a temporary setback. This reduces resilience, makes leverage metrics unfavorable, limits access to financial flexibility and leaves the company more exposed to refinancing pressure.

Weak And Unstable Cash Generation

Negative operating and free cash flow in 2025, alongside repeated weakness in earlier periods, shows that reported earnings have not consistently converted into cash. Unstable cash generation can constrain investment, debt service and working-capital funding over the next several quarters.

Falling Revenue And Weak Core Profitability

The sharp 2025 revenue decline, thin gross margins and recurring negative EBIT point to weak underlying operating performance. This combination limits operating leverage, makes earnings less durable and increases dependence on an eventual recovery in sales or product mix.

Global Bio-chem Technology Group Co. Ltd. News

0809 FAQ

What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was HK$0.31 and its highest was HK$0.89 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is HK$565.36M.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Aug 28, 2026. The company reported -HK$0.123 earnings per share for the quarter.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. pays a Semiannually dividend of HK$0.2 which represents an annual dividend yield of ―. See more information on Global Bio-chem Technology Group Co. Ltd. dividends here
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 1,683,277,100 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of -HK$0.123 in its last earnings report. Following the earnings report the stock price went down -3.797%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:0809
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology